ImmuCell (ICCC)
(Delayed Data from NSDQ)
$6.00 USD
-0.37 (-5.81%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.09 +0.09 (1.50%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, ImmuCell Corporation has a market cap of $57.57M, which represents its share price of $6.37 multiplied by its outstanding shares number of 9.04M. As a small-cap company, ICCC's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ICCC 6.00 -0.37(-5.81%)
Will ICCC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ICCC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ICCC
ImmuCell Upgraded to Outperform on Sales Surge & FDA Upside
The Zacks Analyst Blog Highlights Alphabet, Oracle, Shell, Fossil and ImmuCell
ICCC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top Research Reports for Alphabet, Oracle & Shell
ImmuCell Reports Y/Y Q1 Earnings Growth on Record Sales & Margin Gains
The Zacks Analyst Blog Netflix, SAP SE, Shell, Preformed Line Products and ImmuCell
Other News for ICCC
ICCC Plans Capacity Upgrade to Meet North American Market Demand | ICCC Stock News
Immucell reports preliminary unaudited Q1 revenue $6.4M vs. $5.5M last year
ImmuCell (ICCC) Stock Trading Resumes | ICCC Stock News
ImmuCell (ICCC) Trading Halted Due to Volatility | ICCC Stock News
ImmuCell trading resumes